FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump to award Medal of Freedom to former pitcher Roger Clemens

SCOTUS Bought Congress Time on Deportations: Now Is the Time to Spend It

NFL All-Pro Draws Big Response by Posting a Video from Inside Trump’s Car

Ken Paxton calls out James Talarico’s 11-day absence at Trump rally, prompting response from campaign

Trump heckled multiple times at Texas rally for Ken Paxton, blames ‘paid protesters’

FIRST ON FOX: US Coast Guard recruits largest class in nearly 40 years, beats goals for third straight year

Zach Bryan’s ‘Free Palestine’ Shirt Also Contained a Second Message – It Doesn’t Help His Case

GOP Senate hopeful sounds alarm after alleged Mall of America terror plot thwarted

Manning: Let’s Talk About Mamdani Defending Hamas on Oct. 7 and Exactly What They Did to Their Female Victims

House Democratic candidate denies illegal immigrant arrested by ICE works for campaign

Driver opens fire on strangers along major US interstate, tells cops he ‘had to kill people today’

DHS proposes massive $70K fee for foreign students seeking work authorization

Anti-Israel groups rally across US on October 7 anniversary, chanting ‘long live the intifada’

Judge weighs bid to dismiss soldier’s case over Polymarket bets tied to Maduro raid

Mom dies shielding baby in horrific 15-story Bronx fall as police hunt suspect: report

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”